Axis Securities raised its target price on Navin Fluorine to ₹8,600 from ₹8,000 per share while maintaining its 'Buy' rating. The brokerage said NFIL maintains a highly optimistic outlook for ...

Navin Fluorine International, one of India's leading speciality fluorochemicals manufacturers, reported a more than two-fold jump in June quarter net profit, supported by strong revenue growth and ...

The Portland Trail Blazers' recent draft history has helped them return to relevancy as a playoff team in the Western Conference. Portland Trail Blazers On SI Roger Federer celebrated upon his return ...

Lucas Kloberdanz-Dyck is a writer for Collider. He grew up creating lists, stories, and worlds, which led to his love of anime and video games. He attended Sheridan College where he earned an Honours ...

For someone whose office has a view of a carnival, Lonny Warner is decidedly unwhimsical. The CEO of Reddy Ice, the largest producer of packaged ice in North America, Warner is tall and broad in ...

Congo says Ebola outbreak spreads to northeastern Bas-Uele province Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions of ...

When launching a drug as big as semaglutide, even as a generic, the market expectations are immense, and any fumble on the part of the drugmaker can take a toll. Case in point, Dr. Reddy’s share price ...

Vivek K. Reddy, MD, MMM, has been named Chief Health Informatics Officer for University of Utah Health, effective July 1, 2026. Reddy has served as interim in this role since May 2024, providing ...

A June inspection now has the FDA hitting Dr. Reddy’s with a Form 483, with seven observations spotted at its Indian biologics plant in Hyderabad during a site visit that wrapped up this week. The ...

Add Popular Science (opens in a new tab) More information Adding us as a Preferred Source in Google by using this link indicates that you would like to see more of our content in Google News results.